Category: Joint ventures/collaborations
-
Trial Shows Malaria Vaccine Protects Young Children
Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections.
-
Trials Adding Covid-19 Hospital, Out-Patient Therapies
National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.
-
Mobile App Studied to Measure Kidney Disease Anemia
A smartphone app designed to non-invasively estimate hemoglobin levels is being assessed for its ability to measure anemia in chronic kidney disease patients.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-
Arthritis Drug Unsuccessful for Covid-19 Hospital Patients
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease.
-
First U.S. Quantum Tech Incubator Underway
The first incubator program in the U.S. for start-up enterprises developing quantum technologies is now accepting applicants in Chicago.
-
Infographic – Covax Begins Vaccine Deliveries
Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway.
-
Joint Venture Developing Oral Covid-19 Vaccine
Two biotechnology companies are forming a new enterprise to produce a vaccine as a capsule or tablet to protect against Covid-19 infections.
-
New Covid-19 mRNA Vaccine Trial Begins
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi.